Sign In
Buy CVAC
$4.66
+0 (+0%)
At Close: Apr 02, 2026
CureVac (CVAC) Up on Deal With Bayer for COVID-19 Vaccine
10:32am, Friday, 08'th Jan 2021
CureVac (CVAC) gains on a collaboration agreement with Bayer (BAYRY) for further development and supply of its COVID-19 vaccine candidate, CVnCoV.
Why Coronavirus Stock CureVac Crushed It on Thursday
06:40pm, Thursday, 07'th Jan 2021
The coronavirus vaccine developer announced a new partnership with a major player on the global pharmaceutical scene.
CureVac Secures Bayer as a Partner for Its Coronavirus Vaccine
02:04pm, Thursday, 07'th Jan 2021
Sometimes you need a little help from a big brother.
CureVac Shares Rip Higher On Coronavirus Vaccine Deal With Bayer
12:17pm, Thursday, 07'th Jan 2021
CureVac BV (NASDAQ: CVAC) shares have received a nice lift and breached the $100 level for the first time in the new year. What Happened: German coronavirus vaccine maker CureVac said Thursday it has
CVAC Soars on Bayer COVID-19 Vaccine Collaboration
10:05am, Thursday, 07'th Jan 2021
The shares of CureVac BV (NASDAQ:CVAC) are soaring this morning, up 18.5% at $102.88 at last check.
IBD Announces 100 Best Companies of 2020
10:00am, Thursday, 07'th Jan 2021
LOS ANGELES--(BUSINESS WIRE)---- $CVAC #COVID19--Investor's Business Daily (IBD), a leading financial news and research organization, today announced its list of the 100 Best Companies of 2020. Compan
CureVac Forms Covid-19 Vaccine Alliance With Bayer. The Stock Is Surging.
08:53am, Thursday, 07'th Jan 2021
The German biotech struck a deal with chemicals-and-drugs giant Bayer to accelerate the development and supply of its Covid-19 vaccine candidate.
CureVac strikes COVID-19 vaccine alliance deal with Bayer -Bild
06:11pm, Wednesday, 06'th Jan 2021
German biotech firm CureVac has agreed to an alliance with drugmaker Bayer to get global support in seeking approval for its experimental COVID-19 vaccine and for distribution, daily Bild reported.
4 Small COVID-19 Vaccine Makers to Look Out for in 2021
08:17am, Friday, 18'th Dec 2020
Here we discuss four small biotech companies, NVAX, CVAC, VXRT and ARCT, that are making COVID-19 vaccine candidates, which may be approved in 2021, if successfully developed, and bring profits.
How CureVac Is Advancing in the Fight Against COVID-19
10:01am, Monday, 14'th Dec 2020
CureVac N.V. (NASDAQ: CVAC) advanced in the fight against COVID-19 by beginning enrollment in its midstage vaccine candidate study.
CureVac starts Phase 3 clinical trial of its Covid-19 vaccine candidate
07:56am, Monday, 14'th Dec 2020
Tübingen-based CureVac said the Phase 3 trial will include more than 35,000 volunteers in Europe and Latin America
Is It Too Late to Get in on This Millionaire-Maker Stock?
07:03am, Saturday, 12'th Dec 2020
A biotech that no one has heard of has been making a few investors rich for much of 2020.
2 Surprising Coronavirus Vaccine Stocks to Buy Right Now
06:40am, Thursday, 03'rd Dec 2020
If we judge by return on investment, these two mid-cap biotechs may be the ultimate winners of the coronavirus vaccine race.
COVID Vaccine Stocks Update: Where Things Stand Now
06:08am, Wednesday, 02'nd Dec 2020
Here's what you need to know about all of the leaders in the coronavirus vaccine race.
This Under-the-Radar COVID Vaccine Stock Has a Tesla Tie-In
06:10am, Friday, 27'th Nov 2020
And it's not too far behind coronavirus vaccine leaders Pfizer and Moderna.
